What Is Pentadecanoic Acid (C15:0)? Benefits and How It Works

Pentadecanoic acid (C15:0) is a 15-carbon saturated fatty acid found mainly in dairy fat that early research links to cardiometabolic health.

A glass of whole milk delivers a compound scientists are still figuring out. Pentadecanoic acid, usually shortened to C15:0, shows up in trace amounts in dairy fat and some fish and plants, and it has moved from lab curiosity to supplement aisle in a few short years. What the research actually supports is narrower than the marketing suggests — and knowing the difference matters before you spend money. This breakdown covers what C15:0 is, how it appears to work, what the human trials show, and where the evidence runs out.

What Is Pentadecanoic Acid And Where Does It Come From?

Pentadecanoic acid is an odd-chain saturated fatty acid with 15 carbon atoms, found naturally in small amounts in dairy fat, with lesser quantities reported in some fish and plants. “Odd-chain” matters here: most saturated fats in the diet have an even number of carbons, and C15:0’s odd structure gives it a different metabolic route.

Dietary exposure from moderate grass-fed dairy intake is estimated at roughly 20–50 mg per day. That is an estimate of what people eat, not a target anyone set. No major health authority has established a recommended daily intake, a deficiency definition, or an approved medical use for C15:0.

How Does C15:0 Work In The Body?

Experimental research points to several pathways, but all of them come from cell, animal, observational, or early human studies — not from trials proving C15:0 prevents or treats disease.

• Energy metabolism: breakdown of C15:0 produces propionyl-CoA, which can feed into the tricarboxylic-acid cycle, the cell’s central energy engine.
• Cell signaling: lab work indicates activity at PPARα and PPARδ, receptors that regulate lipid oxidation and glucose metabolism.
• Other proposed routes: studies report AMPK activation, mTOR inhibition, effects on mitochondrial function, and modulation of inflammatory signaling.

These mechanisms are plausible and worth studying. They are not proof that a capsule changes your health outcomes.

Do The Benefits Hold Up? What The Evidence Shows

The strongest human data is observational: people with higher circulating C15:0 levels tend to have lower rates of cardiometabolic disease, type 2 diabetes, and mortality. Association is not causation, and healthier people may simply eat more dairy.

Liver health is an active area: C15:0 has been studied in relation to fatty liver disease, but clinical prevention or treatment efficacy remains unproven. If you are comparing products, see our breakdown of the best pentadecanoic acid supplement options before buying.

Is C15:0 Safe, And What About Dosage?

Short-term human data looks reassuring, but it is thin: tolerability has only been studied at roughly 100–200 mg per day for 12 weeks, and long-term safety is not characterized.

The 200 mg daily dose used in the randomized trial was a study protocol in young adults with overweight or obesity — not a general-population recommendation. A separate review describes a 100 mg/day trial and a 200 mg/day trial showing favorable lipid trends without an LDL-cholesterol increase. Neither tested heart outcomes.

Pregnancy deserves real caution. A mouse study found that 1% dietary C15:0 produced mild maternal glucose intolerance and altered offspring growth-related signaling — a dose and model that cannot be translated into a human supplement amount. Animal work over 14 days reported no mortality, abnormal behavior, major organ-weight changes, or significant histologic abnormalities, but animal findings cannot establish human long-term safety.

People with diabetes, dyslipidemia, liver disease, cardiovascular disease, or anyone taking medication should not swap C15:0 for clinical care. Drug-interaction, renal, hepatic, and long-term reproductive data remain limited.

A few interpretation traps are worth naming. Observational links are not proof. C15:0 is not an established “essential fatty acid.” Cell and animal results do not automatically apply to humans. Dairy intake does not deliver a therapeutic dose. And 100–200 mg/day is not an officially recommended intake. The Nature study on C15:0 and metabolic markers adds useful context on the C15:0 metabolic research.

Each step of deciding whether to try it comes down to the same test: pick the question that matters to you — heart, liver, energy — and check whether a human trial at a real dose actually measured it. If the answer is no, you are looking at a hypothesis, not a benefit.